Biblio
GATA6 suppression enhances lung specification from human pluripotent stem cells. J Clin Invest. 2018.
. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.
. Generation of a human Tropomyosin 1 knockout iPSC line. Stem Cell Res. 2023;71:103161.
. Generation of CHOPe003-A ESC line to study an ACTG2 variant affecting smooth muscle development and function. Stem Cell Res. 2023;71:103186.
. Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells. J Vis Exp. 2019;(151).
. Generation of human control iPSC line CHOPi004-A from juvenile foreskin fibroblast cells. Stem Cell Res. 2020;49:102084.
. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res. 2018;34:101361.
. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells. Curr Protoc. 2022;2(11):e590.
. Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching. Nat Commun. 2023;14(1):2628.
Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Blood Adv. 2024.
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Reports. 2021.
Tropomyosin 1 deficiency facilitates cell state transitions to enhance hemogenic endothelial cell specification during hematopoiesis. bioRxiv. 2023.
.